GlassScriptPhysician profile
Priya Bansal
NPI 1760878847
$126,615.84
in general payments reported to CMS, 2019-2025
30 companies · $1,751 in 2025
The $1,751 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2021: $1,060 · 2022: $891 · 2023: $118K · 2024: $4,657 · 2025: $1,751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $113K · Food and Beverage: $11K · Travel and Lodging: $392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $113,125.00 |
| Food and Beverage | $10,999.71 |
| Travel and Lodging | $391.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $101,824.44 | 2021-2024 | Avvigo Guidance System, Emblem Mri S-Icd, Comet |
| Medtronic, INC. | $13,284.71 | 2023-2024 | Corevalve Evolut R, Symplicity G3, Cobalt Dr Mri Surescan |
| Edwards Lifesciences Corporation | $6,508.09 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abiomed | $987.00 | 2021-2025 | Impella |
| Shockwave Medical, INC | $801.09 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $487.94 | 2021-2024 | Coroflow, Aveir |
| Heartflow, INC. | $475.72 | 2023-2025 | Ffrct |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $418.40 | 2022-2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $225.72 | 2021-2025 | Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $168.54 | 2023-2025 | Jardiance, Spiriva Respimat |
| Cvrx, INC. | $166.66 | 2024 | Barostim Neo System |
| Csl Behring | $146.56 | 2024-2025 | Kcentra |
| Penumbra, INC. | $145.73 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $121.83 | 2025 | Camzyos |
| Novartis Pharmaceuticals Corporation | $120.15 | 2021-2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $116.34 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals LP | $96.07 | 2019-2025 | Wainua, Farxiga |
| Vifor Pharma, INC. | $91.26 | 2022 | |
| Pfizer INC. | $77.38 | 2024-2025 | |
| Alnylam Pharmaceuticals INC. | $53.45 | 2025 | Amvuttra |
| Merck Sharp & Dohme LLC | $44.25 | 2024 | Verquvo |
| Zoll Circulation INC | $41.00 | 2022 | |
| Janssen Pharmaceuticals, INC | $38.22 | 2022 | |
| Astellas Pharma US INC | $37.19 | 2021 | |
| Kestra Medical Technology Services, INC. | $34.68 | 2025 | Assure Wcd |
| Glaxosmithkline, LLC. | $29.72 | 2025 | Nucala |
| Novo Nordisk INC | $20.98 | 2025 | Wegovy |
| Amgen INC. | $20.82 | 2025 | Repatha |
| Lexicon Pharmaceuticals, INC. | $16.96 | 2024 | |
| Chiesi USA, INC. | $14.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priya Bansal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.